Clinical Trials Browser

Terminated × Stomach Neoplasms × camrelizumab × Clear all

NCT04294784 2024-11-04

Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms